Clinical Trial Update: Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of dasatinib, temsirolimus, and cyclophosphamide for advanced malignant solid tumors and recurrent brain neoplasms; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Solid Tumors

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Sprycel (dasatinib)
• Torisel (Temsirolimus)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Solid Neoplasm, Recurrent Brain Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING